Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
77%
Leukemia Cell
49%
Therapeutic Procedure
42%
Cells
40%
T Cell
39%
Cancer
29%
Tumor Microenvironment
29%
B Cell
24%
Patient
23%
Engraftment
23%
Analysis
23%
Immunomodulatory Drug
23%
Lenalidomide
23%
Extracorporeal Membrane Oxygenation
23%
Adult
23%
Respiratory Failure
23%
Artificial Respiration
23%
Growth
23%
Immunity
23%
Combination Therapy
15%
Diffuse Large B-Cell Lymphoma
15%
Follicular Lymphoma
15%
B Lymphocyte Receptor
11%
Antineoplastic Activity
7%
Rituximab
7%
Avadomide
7%
Immune Response
7%
Stromal Cell
7%
Non-Hodgkin Lymphoma
7%
Disease Exacerbation
7%
Tumor Progression
7%
Aptitude
7%
Antigen Recognition
7%
Mantle Cell Lymphoma
7%
Cellular Compartment
7%
Lymphosarcoma
7%
Continuous Positive Airway Pressure
6%
Knock Out
5%
Immunology and Microbiology
Leukemia Cell
100%
Cytotoxic T-Cell
97%
B Cell
56%
Interferon Type I
29%
Engraftment
23%
Follicular B Helper T Cells
23%
Stroma
23%
Programmed Death-Ligand 1
23%
Interleukin 27
23%
T Cell Subset
20%
T Cell Activation
20%
Regulatory T Cell
17%
T Cell Receptor
14%
T-Helper Cell
9%
Xenograft
8%
Transcriptome
7%
Exosome
7%
Next Generation Sequencing
7%
Blocking Antibody
7%
Lymphoid Tissue
6%
Arm
6%
Immune Checkpoint Blockade
5%
Immune Tolerance
5%
T Helper Cell
5%
Immunosuppressive Drug
5%